Free Trial

Haleon (HLN) Competitors

Haleon logo
GBX 381.10 +0.50 (+0.13%)
(As of 12/20/2024 12:01 PM ET)

HLN vs. ULVR, SGE, SN, WHR, ANP, CLX, TPX, PNPL, LEG, and HIK

Should you be buying Haleon stock or one of its competitors? The main competitors of Haleon include Unilever (ULVR), The Sage Group (SGE), Smith & Nephew (SN), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), and Hikma Pharmaceuticals (HIK).

Haleon vs.

Unilever (LON:ULVR) and Haleon (LON:HLN) are both large-cap consumer defensive companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, media sentiment, analyst recommendations, risk, institutional ownership, profitability, earnings and community ranking.

Unilever has higher revenue and earnings than Haleon. Unilever is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Unilever£60.29B1.88£6.64B£2.202,072.27
Haleon£11.26B3.06£1.09B£0.123,175.83

In the previous week, Unilever had 2 more articles in the media than Haleon. MarketBeat recorded 2 mentions for Unilever and 0 mentions for Haleon. Unilever's average media sentiment score of 0.37 beat Haleon's score of 0.25 indicating that Unilever is being referred to more favorably in the media.

Company Overall Sentiment
Unilever Neutral
Haleon Neutral

Unilever has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500.

Unilever pays an annual dividend of GBX 147 per share and has a dividend yield of 3.2%. Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.6%. Unilever pays out 6,681.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Haleon pays out 5,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Unilever has a net margin of 11.01% compared to Haleon's net margin of 9.66%. Unilever's return on equity of 32.37% beat Haleon's return on equity.

Company Net Margins Return on Equity Return on Assets
Unilever11.01% 32.37% 8.62%
Haleon 9.66%6.82%4.45%

54.4% of Unilever shares are held by institutional investors. Comparatively, 43.9% of Haleon shares are held by institutional investors. 0.1% of Unilever shares are held by insiders. Comparatively, 10.7% of Haleon shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Unilever currently has a consensus price target of GBX 4,665, indicating a potential upside of 2.33%. Haleon has a consensus price target of GBX 415, indicating a potential upside of 8.90%. Given Haleon's stronger consensus rating and higher probable upside, analysts plainly believe Haleon is more favorable than Unilever.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Unilever
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Haleon
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Unilever received 1003 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 58.18% of users gave Unilever an outperform vote while only 29.73% of users gave Haleon an outperform vote.

CompanyUnderperformOutperform
UnileverOutperform Votes
1014
58.18%
Underperform Votes
729
41.82%
HaleonOutperform Votes
11
29.73%
Underperform Votes
26
70.27%

Summary

Unilever beats Haleon on 13 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HLN vs. The Competition

MetricHaleonDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£34.45B£1.15B£5.12B£1.68B
Dividend Yield1.61%3.04%4.91%11.86%
P/E Ratio3,175.83131.2391.341,647.28
Price / Sales3.061,962.971,116.63344,513.94
Price / Cash21.9510.1142.5837.88
Price / Book2.093.054.792.81
Net Income£1.09B£152.21M£120.07M£149.14M
7 Day Performance-0.23%-0.55%-1.90%-1.78%
1 Month Performance2.34%-1.39%11.43%15.73%
1 Year Performance18.80%98.64%30.59%26.55%

Haleon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HLN
Haleon
0.6414 of 5 stars
GBX 381.10
+0.1%
GBX 415
+8.9%
+18.3%£34.45B£11.26B3,175.8325,408
ULVR
Unilever
0.379 of 5 stars
GBX 4,645
-0.4%
GBX 4,665
+0.4%
+20.3%£115.20B£60.29B2,119.55148,000
SGE
The Sage Group
1.5663 of 5 stars
GBX 1,299
-0.7%
GBX 3,918
+201.6%
+9.9%£12.94B£2.25B4,982.6911,326
SN
Smith & Nephew
3.7042 of 5 stars
GBX 998.20
+0.5%
GBX 3,956.20
+296.3%
-6.8%£8.70B£5.64B3,697.0418,452Insider Trade
News Coverage
High Trading Volume
WHR
Warehouse REIT
1.7053 of 5 stars
GBX 79.80
-1.1%
GBX 108
+35.3%
-15.5%£339.04M£51.03M1,002.5061,000
ANP
Anpario
1.0397 of 5 stars
GBX 385.70
-0.7%
GBX 370
-4.1%
+39.2%£65.22M£32.72M2,111.67109
CLX
Calnex Solutions
3.143 of 5 stars
GBX 65
+0.9%
GBX 115
+76.9%
+3.0%£56.91M£16.27M1,756.339,000Positive News
TPX
TPXimpact
N/AGBX 44.70
+1.6%
N/A+1.2%£40.82M£84.27M-183.3312,000Gap Down
PNPL
Pineapple Power
N/AN/AN/A+0.0%£2.28MN/A-274.002High Trading Volume
LEG
Legendary Investments
N/AGBX 0.09
-5.6%
N/A+0.0%£0.00N/A0.0019,900News Coverage
Gap Down
HIK
Hikma Pharmaceuticals
1.5415 of 5 stars
GBX 1,937
+0.2%
GBX 2,383.33
+23.0%
+8.3%£4.30B£3.02B2,975.389,100News Coverage

Related Companies and Tools


This page (LON:HLN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners